Visitors since Nov-2012

Researches done on Extra pharmacopoeial drugs (Anukta Dravyas) belonging to Terminalia Genus – A systematic review and Meta-analysis.

National Journal Of Research in Ayurved Science

Article pdf download
Publication Certificate

Keywords

Terminalia genus, medicinal properties, extra pharmacopoeial drugs

How to Cite

Gaonkar, N. (1). Researches done on Extra pharmacopoeial drugs (Anukta Dravyas) belonging to Terminalia Genus – A systematic review and Meta-analysis. National Journal of Research in Ayurved Science, 7(4). Retrieved from http://www.ayurlog.com/index.php/ayurlog/article/view/396

Abstract

The aim of this work was to systematically review and Meta-analyze the researches done on extra pharmacopoeial drugs (anukta dravyas) belonging to Terminalia genus. Terminalia is the second largest genus of family Combrataceae. Plants of the genus Terminalia are amongst the most widely used plants for traditional medicinal purposes worldwide. Many species are used for their antibacterial, antifungal, antiprotozoal, antiviral, antidiarrhoeal, analgesic, antimalarial, anti oxidant, anti inflammatory and anticancer activities. Indeed, the Indian species Terminalia chebula is known as the king of plants in Ayurveda due to its broad range of medicinal uses. However, apart from the reported ethnopharmacological uses of many Terminalia species, surprisingly few studies have rigorously examined this important genus for their medical properties/mechanisms. The last decade has seen a large increase in the number of studies into the use of Terminalia species as therapeutic agents. Data collected till 2018, showed around 120 different databases, articles and researches done on medicinal properties of plants belonging to Terminalia species. It was observed that out of the 250 species of Terminalia genus, research work of 80 plants was done which claimed their potential as medicines.

Article pdf download
Publication Certificate

References

1. Stace CA. The significance of the leaf epidermis in the taxonomy of the Combretaceae, I. A general review of tribal, generic and specific characters. The Journal of the Linnean Society. 1965; 59:229-52.
2. MHRA British Pharmacopoeia, 8th ed. MHRA Regulation Medicines and Medical Devices. UK: BP Publications; 2014.
3. Baliga MS, Meera S, Mathai B, Rai MP, Pawar V, Palatty PL. Scientific Validation of the Ethnomedicinal Properties of the Ayurvedic Drug Triphala: A Review. Chinese Journal of Integrative Medicine. 2012; 18 (12):946-54.
4. O. Silva* and R. Serrano, Terminalia genus as a source of antimicrobial agents, The Battle Against Microbial Pathogens: Basic Science, Technological Advances and Educational Programs (A. Mendez-Vilas, Ed.) FORMATEX 2015.
5. I.E.Cook, The medicinal properties and phytochemistry of plants of the genus Terminalia (Combretaceae), Inflammopharmacology DOI 10.1007/s10787-015-0246-z.
6. Fahmy, NM, Al-Sayed E and Singab AN, Genus Terminalia: Aphytochemical and biological Review, Medicinal & Aromatic Plants,2015, Volume 4, Issue 5, 100218ISSN: 2167-0412.

I  declare (on behalf of me and my co-authors) that the submitted manuscript titled has not previously been published and is not currently being considered elsewhere for publication in another journal and that I am (we are) the sole owner(s) of the manuscript thereof and of all rights, title, and interest therein. All agreed to the terms and conditions, Privacy Policy, which is declared on Journal Website http://www.ayurlog.com and online filled (uploaded) form

Abstract

The aim of this work was to systematically review and Meta-analyze the researches done on extra pharmacopoeial drugs (anukta dravyas) belonging to Terminalia genus. Terminalia is the second largest genus of family Combrataceae. Plants of the genus Terminalia are amongst the most widely used plants for traditional medicinal purposes worldwide. Many species are used for their antibacterial, antifungal, antiprotozoal, antiviral, antidiarrhoeal, analgesic, antimalarial, anti oxidant, anti inflammatory and anticancer activities. Indeed, the Indian species Terminalia chebula is known as the king of plants in Ayurveda due to its broad range of medicinal uses. However, apart from the reported ethnopharmacological uses of many Terminalia species, surprisingly few studies have rigorously examined this important genus for their medical properties/mechanisms. The last decade has seen a large increase in the number of studies into the use of Terminalia species as therapeutic agents. Data collected till 2018, showed around 120 different databases, articles and researches done on medicinal properties of plants belonging to Terminalia species. It was observed that out of the 250 species of Terminalia genus, research work of 80 plants was done which claimed their potential as medicines.